申请人:Naganuma Kenji
公开号:US20060293343A1
公开(公告)日:2006-12-28
The object of the invention is to provide a novel compound having an inhibitory action on PDE4 activity with fewer side effects.
The invention provides a compound represented by the following general formula (1), possible stereoisomers thereof or racemates thereof, pharmacologically acceptable salts thereof, hydrates thereof, solvated compounds thereof, or prodrugs thereof,
本发明的目的是提供一种对PDE4活性具有抑制作用且副作用较少的新型化合物。
该发明提供了一种由以下一般式(1)表示的化合物,其可能的立体异构体或外消旋体,其药理学上可接受的盐,水合物,溶剂化合物,或前药。